Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D006801:Humans; D008297:Male; D008715:Methionine / Q000494:pharmacology*; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D011600:Psychopharmacology; D012559:Schizophrenia / Q000378:metabolism*; D014191:Tranylcypromine / Q000494:pharmacology*; D014363:Tryptamines / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism / Q000494:pharmacology*; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D002395:Catecholamines; D014363:Tryptamines; D014191:Tranylcypromine; D014364:Tryptophan; D008715:Methionine; D009638:Norepinephrine